These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 32969044)

  • 1. Clinical benefits of sex steroids given as a priming prior to GH provocative test or as a growth-promoting therapy in peripubertal growth delays: Results of a retrospective study among ENDO-ERN centres.
    Galazzi E; Improda N; Cerbone M; Soranna D; Moro M; Fatti LM; Zambon A; Bonomi M; Salerno M; Dattani M; Persani L
    Clin Endocrinol (Oxf); 2021 Feb; 94(2):219-228. PubMed ID: 32969044
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sex steroid priming for growth hormone stimulation testing in children and adolescents with short stature: A systematic review.
    Duncan G; Kiff S; Mitchell RT
    Clin Endocrinol (Oxf); 2023 Apr; 98(4):527-535. PubMed ID: 36515075
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Responses to growth hormone (GH) therapy in short children with normal GH secretion and no bone age delay: an analysis of potential factors affecting their response to rhGH therapy. A controlled study.
    Soliman AT; Elawwa A; Itani M; Jour C; De Sanctis V
    Acta Biomed; 2019 Sep; 90(8-S):43-51. PubMed ID: 31544806
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sex steroid priming in short stature children unresponsive to GH stimulation tests: Why, who, when and how.
    Partenope C; Galazzi E; Albanese A; Bellone S; Rabbone I; Persani L
    Front Endocrinol (Lausanne); 2022; 13():1072271. PubMed ID: 36523598
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Final heights of boys with normal growth hormone responses to provocative tests following priming.
    Gonc EN; Kandemir N; Ozon A; Alikasifoglu A
    J Pediatr Endocrinol Metab; 2008 Oct; 21(10):963-71. PubMed ID: 19209618
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Is the growth outcome of children with idiopathic short stature and isolated growth hormone deficiency following treatment with growth hormone and a luteinizing hormone-releasing hormone agonist superior to that obtained by GH alone?
    Colmenares A; González L; Gunczler P; Lanes R
    J Pediatr Endocrinol Metab; 2012; 25(7-8):651-7. PubMed ID: 23155689
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Growth response to growth hormone (GH) treatment in children with GH deficiency (GHD) and those with idiopathic short stature (ISS) based on their pretreatment insulin-like growth factor 1 (IGFI) levels and at diagnosis and IGFI increment on treatment.
    Soliman A; Rogol AD; Elsiddig S; Khalil A; Alaaraj N; Alyafie F; Ahmed H; Elawwa A
    J Pediatr Endocrinol Metab; 2021 Oct; 34(10):1263-1271. PubMed ID: 34291621
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of growth hormone therapy on Taiwanese children with growth hormone deficiency.
    Huang YH; Wai YY; Van YH; Lo FS
    J Formos Med Assoc; 2012 Jul; 111(7):355-63. PubMed ID: 22817812
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Growth Hormone Deficiency (GHD) Reversal Trial: effect on final height of discontinuation versus continuation of growth hormone treatment in pubertal children with isolated GHD-a non-inferiority Randomised Controlled Trial (RCT).
    Brettell E; Högler W; Woolley R; Cummins C; Mathers J; Oppong R; Roy L; Khan A; Hunt C; Dattani M;
    Trials; 2023 Aug; 24(1):548. PubMed ID: 37605233
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Growth response, pubertal growth and final height in Greek children with growth hormone (GH) deficiency on long-term GH therapy and factors affecting outcome.
    Karavanaki K; Kontaxaki C; Maniati-Christidi M; Petrou V; Dacou-Voutetakis C
    J Pediatr Endocrinol Metab; 2001 Apr; 14(4):397-405. PubMed ID: 11327373
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential diagnosis between constitutional delay of growth and puberty, idiopathic growth hormone deficiency and congenital hypogonadotropic hypogonadism: a clinical challenge for the pediatric endocrinologist.
    Galazzi E; Persani LG
    Minerva Endocrinol; 2020 Dec; 45(4):354-375. PubMed ID: 32720501
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Growth hormone responses during arginine and clonidine stimulation test: Correlations with patients' auxological and metabolic parameters in a single centre study.
    Sodero G; Mariani F; Caprarelli M; Agazzi C; Quarta L; Benacquista L; Rigante D; Clelia C
    Growth Horm IGF Res; 2023 Feb; 68():101522. PubMed ID: 36502626
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Secondary IGF-I deficiency as a prognostic factor of growth hormone (GH) therapy effectiveness in children with isolated, non-acquired GH deficiency.
    Smyczyńska J; Stawerska R; Hilczer M; Lewiński A
    Exp Clin Endocrinol Diabetes; 2015 Apr; 123(4):209-14. PubMed ID: 25607339
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Growth Responses During 3 Years of Growth Hormone Treatment in Children and Adolescents With Growth Hormone Deficiency: Comparison Between Idiopathic, Organic and Isolated Growth Hormone Deficiency, and Multiple Pituitary Hormone Deficiency.
    Lim HH; Kim YM; Lee GM; Yu J; Han HS; Yu J
    J Korean Med Sci; 2022 Mar; 37(11):e90. PubMed ID: 35315601
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy and safety of growth hormone treatment in children with short stature: the Italian cohort of the GeNeSIS clinical study.
    Cappa M; Iughetti L; Loche S; Maghnie M; Vottero A;
    J Endocrinol Invest; 2016 Jun; 39(6):667-77. PubMed ID: 27223400
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect on adult height of pubertal growth hormone retesting and withdrawal of therapy in patients with previously diagnosed growth hormone deficiency.
    Zucchini S; Pirazzoli P; Baronio F; Gennari M; Bal MO; Balsamo A; Gualandi S; Cicognani A
    J Clin Endocrinol Metab; 2006 Nov; 91(11):4271-6. PubMed ID: 16912138
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Final height in growth hormone-deficient childhood cancer survivors after growth hormone therapy.
    Rodari G; Cattoni A; Albanese A
    J Endocrinol Invest; 2020 Feb; 43(2):209-217. PubMed ID: 31452114
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Is priming with sex steroids useful for defining patients who will benefit from GH treatment?
    De Sanctis V; Soliman AT; Yassin M; Di Maio S
    Pediatr Endocrinol Rev; 2014 Mar; 11(3):284-7. PubMed ID: 24716393
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Relationship between Subnormal Peak-Stimulated Growth Hormone Levels and Auxological Characteristics in Obese Children.
    Barrett J; Maranda L; Nwosu BU
    Front Endocrinol (Lausanne); 2014; 5():35. PubMed ID: 24723909
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Insulin-like growth factor ternary complex components as biomarkers for the diagnosis of short stature.
    Giannakopoulos A; Efthymiadou A; Chrysis D
    Eur J Endocrinol; 2021 Oct; 185(5):629-635. PubMed ID: 34403357
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.